1-3 of 3
Svenja Otterstetter
Close
Sort by
Journal Articles

Translocation t(4;14) Is Not an Adverse Prognostic Factor in Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation.

Timon Hansen, Georgia Schilling, Avichai Shimoni, Jose-Antonio Simon-Perez, Wolfgang Bethge, Peter Liebisch, Rainer Schwerdtfeger, Martin Bornhaeuser, Svenja Otterstetter, Francis Ayuk, Carsten Bokemeyer, Axel R. Zander, Jesus San-Miguel, Arnon Nagler, Nicolaus Kroeger
Journal: Blood
Blood (2007) 110 (11): 4743.
https://doi.org/10.1182/blood.V110.11.4743.4743
Published: 2007
Journal Articles

No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation.

Timon Hansen, Georgia Schilling, MD, Peter Liebisch, MD, Rainer Schwerdtfeger, PD, Jose Antonio Perez-Simon, MD, Martin Bornhaeuser, PD, Svenja Otterstetter, Judith Dierlamm, PD, Arnon Nagler, Dieter Kurt Hossfeld, Carsten Bokemeyer, Axel R. Zander, Nicolaus Kroeger, PD
Journal: Blood
Blood (2006) 108 (11): 5038.
https://doi.org/10.1182/blood.V108.11.5038.5038
Published: 2006
Journal Articles

Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation.

Georgia Schilling, MD, Timon Hansen, Jose Antonio Perez-Simon, MD, Rainer Schwerdtfeger, MD, Martin Bornhaeuser, MD, Svenja Otterstetter, Doris Seeger, Judith Dierlamm, PD, Francis Ayuk, MD, Hossfeld Dieter Kurt, Bokemeyer Carsten, Zander R. Axel, Kroeger Nicolaus, PD
Journal: Blood
Blood (2005) 106 (11): 4338.
https://doi.org/10.1182/blood.V106.11.4338.4338
Published: 2005